Universal Health Services, Inc. (UHS) is an American healthcare management company that owns and operates acute care hospitals, behavioral health facilities, and ambulatory centers. Headquartered in King of Prussia, Pennsylvania, the company operates hundreds of facilities across the United States, Puerto Rico, and the United Kingdom. UHS is distinctive for its dual focus on general medical-surgical care and specialized behavioral health, making it one of the largest providers of psychiatric services in the U.S.
Financial Statements
In thousands, USD
FY 2025
FY 2024
FY 2023
FY 2022
Total Revenues
17,364,800
15,827,900
14,282,000
13,399,400
Cost of Sales
15,370,800
14,146,100
13,106,600
12,395,800
Gross Profit
1,994,020
1,681,810
1,175,380
1,003,560
Operating Profit
1,994,020
1,681,810
1,175,380
1,003,560
Interest Expense
(156,068)
(186,109)
(206,674)
(126,889)
Non-Operating Income
134,194
2,231
(28,281)
(10,406)
Total Non-Operating Income
(21,874)
(183,878)
(234,955)
(137,295)
Income Before Provision for Income Taxes
1,972,140
1,497,940
940,426
866,260
Provision for Income Taxes
460,959
334,827
221,119
209,278
Consolidated Net Income
1,511,180
1,163,110
719,307
656,982
Net Income Attributable to Minority Interests and Other
22,386
21,012
1,512
(18,627)
Net Income Attributable to Common Shareholders
1,488,800
1,142,100
717,795
675,609
Basic EPS
23.42
17.16
10.35
9.23
Diluted EPS
23.10
16.82
10.23
9.14
Basic Weighted Average Shares Outstanding
63,581
66,554
69,321
73,118
Diluted Weighted Average Shares Outstanding
64,462
67,896
70,125
73,832
Shares Outstanding
61,064
64,977
67,182
70,629
FY 2025
FY 2024
FY 2023
FY 2022
Cash and Cash Equivalents
137,797
125,983
119,439
102,818
Total Cash and Cash Equivalents
137,797
125,983
119,439
102,818
Accounts Receivable
2,602,430
2,177,750
2,238,270
2,017,720
Total Trade Receivables
2,602,430
2,177,750
2,238,270
2,017,720
Inventories
232,110
220,940
216,988
218,517
Other Current Assets
435,574
291,614
236,658
198,283
Total Current Assets
3,407,920
2,816,290
2,811,350
2,537,340
Net Property, Plant & Equipment
12,884,700
12,303,400
6,124,530
5,918,460
Goodwill
3,990,210
3,932,880
3,932,410
3,909,460
Other Long-Term Assets
1,121,370
1,148,360
1,099,330
1,128,930
Total Assets
15,527,600
14,469,700
13,967,600
13,494,200
Accounts Payable
750,134
632,001
613,974
636,601
Accrued Expenses
1,668,070
1,463,700
1,195,710
1,126,200
Current Portion of Long-Term Debt
748,158
40,059
126,686
81,447
Current Portion of Leases
73,237
74,649
71,600
67,776
Unearned Revenue
—
—
5,375
—
Other Current Liabilities
1,930
14,219
2,046
7,005
Total Current Liabilities
3,239,600
2,210,410
2,013,350
1,914,420
Long-Term Debt
4,004,390
4,464,480
4,785,780
4,726,530
Leases
340,715
376,239
382,559
487,669
Other Long-Term Liabilities
533,476
655,806
584,007
—
Total Long-Term Liabilities
4,878,580
5,496,530
5,752,350
5,214,200
Total Liabilities
8,118,190
7,706,930
7,765,700
7,128,620
Common Stock
611
650
672
710
Accumulated Other Comprehensive Income
47,783
7,201
9,289
(9,668)
Retained Earnings
7,227,400
6,658,360
6,139,040
5,929,540
Total Common Shareholders' Equity
7,275,790
6,666,210
6,149,000
5,920,580
Minority Interests and Other
133,616
96,609
52,905
49,463
Total Shareholders' Equity
7,409,410
6,762,820
6,201,910
5,970,050
Total Liabilities and Shareholders' Equity
15,527,600
14,469,700
13,967,600
13,494,200
FY 2025
FY 2024
FY 2023
FY 2022
Net Income
1,511,180
1,163,110
719,307
656,982
Depreciation & Amortization
618,743
584,831
568,041
581,861
Share-Based Compensation Expense
95,688
99,349
87,720
85,378
Other Adjustments
(85,323)
(6,762)
(6,250)
58,134
Changes in Trade Receivables
(317,985)
67,355
(182,444)
(258,338)
Changes in Accrued Expenses
(4,053)
12,814
1,193
1,835
Changes in Income Taxes Payable
(21,441)
12,651
(43,450)
(29,510)
Changes in Other Operating Activities
67,586
133,754
123,680
(100,319)
Cash from Operating Activities
1,864,400
2,067,100
1,267,800
996,023
Capital Expenditure
(1,015,150)
(943,810)
(743,055)
(734,001)
Purchases of Intangible Assets
(24,695)
—
—
—
Purchases of Investments
(9,831)
—
—
—
Proceeds from Sale of Investments
63,073
—
—
—
Payments for Business Acquisitions
(47,804)
(18,998)
(3,728)
(20,309)
Proceeds from Business Divestments
15,863
38,563
24,187
12,001
Other Investing Activities
(52,071)
13,136
(40,679)
95,013
Cash from Investing Activities
(1,070,620)
(911,109)
(763,275)
(647,296)
Issuance of Long-Term Debt
285,536
2,210,250
185,100
705,321
Repayments of Long-Term Debt
(43,504)
(2,640,000)
(85,480)
(89,367)
Net Issuance / (Repayments) of Long-Term Debt
242,032
(429,753)
99,620
615,954
Issuance of Common Shares
16,729
15,070
13,654
14,068
Repurchases of Common Shares
(967,951)
(670,754)
(547,363)
(832,918)
Net Issuance / (Repurchases) of Common Shares
(951,222)
(655,684)
(533,709)
(818,850)
Common Share Dividends Paid
(51,267)
(53,346)
(55,480)
(58,449)
Other Financing Activities
10,730
(6,094)
(4,376)
(57,055)
Cash from Financing Activities
(749,727)
(1,144,880)
(493,945)
(318,400)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
2,517
(833)
3,056
(8,424)
Increase / (Decrease) in Cash, Cash Equivalents and Restricted Cash